The GEMINI-T2D study demonstrated that remote monitoring of SMBG data via a glucose management platform, coupled with algorithm-guided insulin titration, may improve glycemic control in patients with insulin-treated T2D. Here, INS is linked to type 2 diabetes mellitus.